CategoriesBritish ChambersCharity SectorConstructionCyber SecurityEducationFinancial & LegalHealth Wellbeing & LeisureInternational TradeIT InsightsJob VacanciesManufacturingMarketingMember NewsPolicySales & Marketing InsightsSussex ShowcaseTransport & Logistics Sector
ArchiveNovember 2020October 2020September 2020August 2020July 2020June 2020May 2020April 2020March 2020February 2020January 2020December 2019November 2019October 2019September 2019August 2019July 2019June 2019May 2019April 2019March 2019February 2019January 2019December 2018November 2018October 2018September 2018August 2018May 2018
Manor Royal business Chemigraphic receives £7m private equity investment
Crawley-based Chemigraphic, the leading provider of Electronic Manufacturing Services (EMS) to the fast-growth medical technology, defence and power systems sectors, today announces that it has received £7 million investment from NVM Private Equity (NVM), from its Vintage III fund.
The investment will help to accelerate Chemigraphic’s international growth and drive continued development of its technology and expertise, particularly in the fast-growing med-tech sector.
Headquartered in Crawley’s prestigious Manor Royal business park, with a sourcing office in China, Chemigraphic builds complex products for a wide range of specialist UK and global technology brands, from conception to production, supporting them at every stage of their product lifecycle. Chemigraphic CEO Chris Wootton, who joined the business in April 2017, has a clear vision to scale the business globally and has a strong track record of creating value for his shareholders throughout his career.
With over 150 staff and experience spanning over four decades, Chemigraphic is now set for a period of strong growth, which has been boosted further by the NVM investment. Chemigraphic’s customers, many of whom have worked with the business for over 15 years, trust them to be involved in the very early stages of new product development for their most complex products, followed by ongoing fulfilment of production.
NVM Private Equity is independently owned with over 30 years’ experience of investing in unquoted UK businesses. NVM is a generalist investor, managing approximately £430 million of funds, and is differentiated by having executives living and working in regional business communities throughout the UK.
Peter Hodson and David Rolfe led the investment for NVM and Peter joined the Chemigraphic board upon completion.
Chris Wootton, CEO of Chemigraphic, said: “Chemigraphic has a fabulous customer base and is extremely well placed to become a significant global provider of Electronic Manufacturing Services (EMS). We are delighted that NVM shares our vision and has decided to invest in and back the team. The investment will enable us to implement planned strategic investments in our global footprint and hence capitalise on a number of extremely exciting growth opportunities. We are very much looking forward to partnering with the NVM team as we embark upon this next exciting phase in our development”.
Peter Hodson, Investment Partner of NVM Private Equity, said: “We are very excited to have the opportunity to work with Chris and his team at Chemigraphic. The business has generated a lot of momentum since Chris joined the company two years ago benefiting from his laser focus on operational excellence and proactive business development. Chemigraphic’s current customer base is highly committed to the company, having benefitted from market leading service levels and product expertise. We are delighted to be coming on board at this exciting stage in the company's development.”